We postulate that these overlapping findings in our PHTS patients suggest that the reduced genomic diversity in the set of specific biological processes could crosstalk with altered PTEN pathway(s) to modify the risk of developing neurodevelopmental phenotypes in PHTS. This evidence concerns the gene PTEN and PTEN hamartoma tumor syndrome.